Your browser doesn't support javascript.
loading
[Clinical and laboratory features of T-cell prolymphocytic leukemia in China].
Zhang, Yan-ru; Qi, Jun-yuan; Liu, Hui-min; Liu, Wei; Huang, Wen-yang; Deng, Shu-hui; Yi, Shu-hua; Xu, Yan; Li, Zeng-jun; Fu, Ming-wei; Zou, De-hui; Zhao, Yao-zhong; Qiu, Lu-gui.
Afiliação
  • Zhang YR; Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin 300020, China.
Zhonghua Xue Ye Xue Za Zhi ; 34(10): 839-43, 2013 Oct.
Article em Zh | MEDLINE | ID: mdl-24171956
ABSTRACT

OBJECTIVE:

To investigate the clinical and laboratory characteristics and survival of Chinese patients with T- cell prolymphocytic leukemia (T-PLL).

METHODS:

Eleven patients with T-PLL admitted in our hospital from Jan 2006 to Oct 2012 were retrospectively analyzed.

RESULTS:

Of the 11 patients, nine were males and two females, with the median age of 56.0(19-69) years old. All the patients, except for three, presented with leukocytosis. The incidence of hyperleukocytosis (1/11) was less frequent than that in the British series (75%) (P=0.000). Lymphocyte counts in peripheral blood were increased in 9 of the 11 patients with the median absolute lymphocyte count (ALC) of 17.22(0.58-148.83)×109/L. Superficial lymphadenopathy and splenomegaly were the most common physical signs. It was common that serum lactate dehydrogenase (LDH) and beta 2 microglobulin(ß2-MG)were higher than normal level. All cases were positive for CD2/CD3/CD5/TCRαß, negative for CD1a /HLA-DR and TdT, and most of them were strong positive for CD7 expression. By chromosome analyses, most cases. (9/10) have normal chromosome. This rate is significantly higher than that of the British and American series (3% and 25%, respectively) (P=0.000, P=0.001). The 14q11 abnormality and trisomy 8q, which are common among Western cases, were not observed in any of our cases. With a median follow-up of 23.0 months, three patients died. Two year progress free survival (PFS) and overall survival (OS) were 53.3% and 50%, respectively. There were 3 patients with PFS over a number of years, whether it should be considered as the T-chronic lymphocytic leukemia (T-CLL) is worthy of further studies.

CONCLUSION:

The common clinical manifestations of T-PLL patients were increased lymphocyte counts and lymphadenopathy as well as splenomegaly. And most cases have high level of blood LDH and ß2- MG and normal chromosome karyotype.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Prolinfocítica de Células T Idioma: Zh Ano de publicação: 2013 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Prolinfocítica de Células T Idioma: Zh Ano de publicação: 2013 Tipo de documento: Article